Overview / Abstract: |
Target Audience This activity has been designed to meet the educational needs of pulmonologists, radiologists, and pathologists. It may also be of benefit to primary care physicians, rheumatologists, PAs, nurse practitioners, nurses, pharmacists, fellows, residents, and other healthcare professionals who care for patients with chronic progressive fibrosing interstitial lung disease (PF-ILD). Program Overview Patients with lingering ILD symptoms after COVID infection may have a genetic predisposition for progressive fibrosing ILD and need to be followed and treated appropriately. Learning Objectives Upon completion of this activity, participants should be better able to: Analyze laboratory and imaging data to diagnose PF-ILD |
Expiration |
Oct 15, 2022 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
0.75 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty Co-Chairs Sonye K. Danoff, MD, PhD Associate Professor of Medicine Erica L. Herzog, MD, PhD Professor of Medicine and Pathology Faculty Consultants Stephen Hobbs, MD, FSCCT Associate Professor of Radiology and Medicine Jonathan A. Kropski, MD Associate Professor of Medicine |
Sponsors / Supporters / Grant Providers |
Paradigm Medical Communications, LLC. |
Keywords / Search Terms |
Relias LLC Relias LLC., FreeCME., Post-COVID Interstitial Lung Disease Free CE CME |